Literature DB >> 15123561

Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult rats.

Takashi Takeuchi1, Hiroshi Kitagawa, Etsumori Harada.   

Abstract

Using adult rats, the characteristic transporting system for lactoferrin (LF) from intestinal lumen into the blood circulation was investigated. The rats were randomly divided into two groups, a non-collected thoracic lymph (NC) group and a collected thoracic lymph (LC) group. Peripheral blood and thoracic lymph were collected from a jugular vein and a thoracic lymph duct, respectively, under anaesthesia. Bovine LF (bLF) was infused into the duodenal lumen by needle over a 1-min period at a dose of 1 g kg(-1). The transported bLF in the plasma and lymph was assayed quantitatively by double-antibody enzyme-linked immunosorbent assay (ELISA). Morphological investigation was also carried out in the intestine, lymph node, and liver. Following intraduodenal administration of bLF, the transported bLF in the NC group was detected in the plasma, and reached a peak value at 2 h. Furthermore, the bLF concentration in the thoracic duct lymph fluid in the LC group increased significantly, and peaked 2 h after the administration. In addition, bLF was not detected in the plasma of the LC group. Immunohistochemical analysis clearly showed anti-bLF positive particles in the epithelial cells of the apical villi. The striated border and baso-lateral membrane were also bLF positive. These results suggest that intraduodenally infused bLF is transported into the blood circulation via the lymphatic pathway, not via portal circulation in adult rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123561     DOI: 10.1113/expphysiol.2003.026633

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  11 in total

1.  Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life.

Authors:  Yasuhiro Nojima; Yosuke Suzuki; Kazuhiro Yoshida; Fumiko Abe; Tuneo Shiga; Takashi Takeuchi; Akihiko Sugiyama; Hirohiko Shimizu; Atsushi Sato
Journal:  Pharm Res       Date:  2009-06-25       Impact factor: 4.200

2.  Lactoferrin and its digestive peptides induce interferon-α production and activate plasmacytoid dendritic cells ex vivo.

Authors:  Shutaro Kubo; Momoko Miyakawa; Asuka Tada; Hirotsugu Oda; Hideki Motobayashi; Sadahiro Iwabuchi; Shinobu Tamura; Miyuki Tanaka; Shinichi Hashimoto
Journal:  Biometals       Date:  2022-08-26       Impact factor: 3.378

3.  Plasma Lactoferrin Levels Positively Correlate with Insulin Resistance despite an Inverse Association with Total Adiposity in Lean and Severely Obese Patients.

Authors:  Sylvain Mayeur; Alain Veilleux; Yves Pouliot; Benoît Lamarche; Jean-François Beaulieu; Frédéric S Hould; Denis Richard; André Tchernof; Emile Levy
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

4.  Antidepressant-like effect of milk-derived lactoferrin in the repeated forced-swim stress mouse model.

Authors:  Takashi Takeuchi; Kana Matsunaga; Akihiko Sugiyama
Journal:  J Vet Med Sci       Date:  2017-09-21       Impact factor: 1.267

5.  The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria.

Authors:  Douglas B Kell; Eugene L Heyden; Etheresia Pretorius
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

6.  No Difference in Lactoferrin Levels between Metabolically Healthy and Unhealthy Obese Women.

Authors:  Małgorzata Jamka; Patrycja Krzyżanowska-Jankowska; Edyta Mądry; Aleksandra Lisowska; Paweł Bogdański; Jarosław Walkowiak
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

7.  Suppressive Role of Lactoferrin in Overweight-Related Female Fertility Problems.

Authors:  Ban Sato; Seiya Kanai; Daiki Sakaguchi; Kodai Yajima; Yu Matsumoto; Kazunori Morohoshi; Shinji Kagaya; Nobuo Izumo; Minoru Ichinose; Woojin Kang; Mami Miyado; Kenji Miyado; Natsuko Kawano
Journal:  Nutrients       Date:  2022-02-22       Impact factor: 5.717

8.  Cardioprotective effects of enteral vs. parenteral lactoferrin administration on myocardial ischemia-reperfusion injury in a rat model of stunned myocardium.

Authors:  Keisuke Omiya; Yosuke Nakadate; Takeshi Oguchi; Tamaki Sato; Toru Matsuoka; Masako Abe; Akiko Kawakami; Takashi Matsukawa; Hiroaki Sato
Journal:  BMC Pharmacol Toxicol       Date:  2022-10-14       Impact factor: 2.605

9.  Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model.

Authors:  Yi-Chieh Li; Chang-Chi Hsieh
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

Review 10.  Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action.

Authors:  Antimo Cutone; Luigi Rosa; Giusi Ianiro; Maria Stefania Lepanto; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci
Journal:  Biomolecules       Date:  2020-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.